Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

From ‘Ozempic face’ to ‘Ozempic fingers’ and even ‘Wegovy butt,’ the potential side effects of weight loss medications have ...

It is the second time in a year that a U.S. court has found Google to have illegally maintained a monopoly. A judge in ...

NEW YORK, April 26: If you're looking to shed some pounds but want to avoid weight-loss drugs like Ozempic, a leading doctor ...

The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...

You'll be happy to know Eli Lilly has created a GLP-1 agonist in pill form, and it may be just as effective at lowering blood ...

As The New York Times explains, peptides are small fragments of proteins ... How does orforglipron compare to drugs like ...

Pharmaceutical company Eli Lilly’s study of its tablet, orforglipron, has raised hopes of an effective and easy-to-use ...